Related Experiment Video
Updated: Apr 4, 2026

12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
6.9K
Robot-assisted retroperitoneal lymph node dissection in testicular cancer
Haidar M Abdul-Muhsin1, James O L'esperance2, Kimberly Fischer2
1Mayo Clinic, Phoenix, Arizona.
Journal of Surgical Oncology
|September 10, 2015
Summary
Robot-assisted retroperitoneal lymphadenectomy (RARPLND) is emerging for testicular cancer. This review covers RARPLND
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Retroperitoneal lymphadenectomy (RPLND) is a standard treatment for testicular cancer.
- Laparoscopic RPLND has faced challenges in widespread adoption.
- Robotic surgical systems offer potential advantages for complex procedures.
Purpose of the Study:
- To review the current application of retroperitoneal lymphadenectomy (RPLND) in testicular cancer management.
- To discuss the evolution of minimally invasive techniques for RPLND.
- To evaluate the emerging role and current status of robot-assisted RPLND (RARPLND).
Main Methods:
- Literature review of robotic surgical techniques in retroperitoneal lymphadenectomy.
- Analysis of emerging reports and controversies surrounding RARPLND.
- Synthesis of current evidence on the application of RARPLND for testicular cancer.
Main Results:
- While laparoscopic RPLND has not gained widespread acceptance, robot-assisted RPLND (RARPLND) is increasingly reported.
- RARPLND presents a potential advancement in minimally invasive RPLND for testicular cancer.
- The manuscript synthesizes current data and discusses the ongoing evolution of this technique.
Conclusions:
- Robot-assisted RPLND (RARPLND) is an emerging technique for testicular cancer surgery.
- Further research and data are needed to fully establish the role and benefits of RARPLND.
- RARPLND may represent the future of minimally invasive RPLND in managing testicular cancer.

